Rapporto sull’analisi delle dimensioni del mercato e delle quote dello screening farmacologico | Previsioni 2031

  • Report Code : TIPHE100000970
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

PANORAMICA DEL MERCATO Lo screening farmacologico è un processo tecnico, eseguito per analizzare campioni come capelli, urina, fluidi orali, respiro e altri campioni. Lo screening farmacologico aiuta a rilevare la presenza di un farmaco o di un composto chimico nel corpo. Questo processo viene applicato negli ospedali, nei centri di test antidroga, nei centri di gestione del dolore e nelle forze dell'ordine. Le aziende e le organizzazioni eseguono anche test di screening antidroga su dipendenti e atleti per verificare l'eventuale abuso di droghe. AMBITO DI MERCATO L'"Analisi del mercato dello screening globale dei farmaci fino al 2031" è uno studio specializzato e approfondito del settore alimentare e delle bevande con particolare attenzione all'analisi delle tendenze del mercato globale. L’obiettivo del rapporto è fornire una panoramica del mercato dello screening farmacologico con una segmentazione dettagliata del mercato per tipo, prodotti, rilevamento di malattie, applicazione e area geografica. Il rapporto fornisce statistiche chiave sullo stato del mercato dei principali attori del mercato screening dei farmaci e offre tendenze e opportunità chiave nel mercato. SEGMENTAZIONE DEL MERCATO
    •  In base al tipo di prodotto, il mercato è segmentato in strumenti analitici, dispositivi di test rapidi e materiali di consumo. •  Sulla base del campione, il mercato globale dello screening farmacologico è segmentato in respiro, capelli, fluido orale, urina e altri. •  In base all'utente finale, il mercato è suddiviso in laboratori di test antidroga, centri di trattamento della droga, sistemi di giustizia penale e forze dell'ordine, centri di gestione del dolore, ospedali, privati e altri
DINAMICHE DEL MERCATO Driver
    •  L'aumento del consumo di alcol e droghe negli anni precedenti è stato motivo di preoccupazione per vari datori di lavoro. •  Vari enti governativi hanno stanziato fondi per i test di screening antidroga. •  Si prevede che lo sviluppo e l’adozione di nuovi metodi e dispositivi per lo screening dei farmaci saranno i fattori trainanti per la crescita del mercato dello screening dei farmaci.
Restrizioni
    •  È probabile che i divieti sul consumo di alcol nei paesi islamici frenino la crescita del mercato. •  Divieto di test antidroga sul posto di lavoro
Il rapporto fornisce una panoramica dettagliata del settore, comprese informazioni sia qualitative che quantitative. Fornisce una panoramica e previsioni del mercato globale in base a vari segmenti. Fornisce inoltre stime sulle dimensioni del mercato e sulle previsioni per l’anno dal 2021 al 2031 rispetto a cinque regioni principali, vale a dire; Nord America, Europa, Asia-Pacifico (APAC), Medio Oriente e Africa (MEA) e Sud America. Il mercato dello screening farmacologico per ciascuna regione viene successivamente suddiviso in sottosegmenti in base ai rispettivi paesi e segmenti. Il rapporto copre l’analisi e le previsioni di 18 paesi a livello globale insieme alla tendenza attuale e alle opportunità prevalenti nella regione. Il rapporto analizza i fattori che influenzano il mercato sia dal lato della domanda che dell'offerta e valuta ulteriormente le dinamiche di mercato che influenzano il mercato durante il periodo di previsione, ovvero fattori trainanti, restrizioni, opportunità e tendenza futura. Il rapporto fornisce anche un'analisi PEST esaustiva per tutte e cinque le regioni, vale a dire; Nord America, Europa, APAC, MEA e Sud America dopo aver valutato i fattori politici, economici, sociali e tecnologici che influenzano il mercato dello screening farmacologico in queste regioni. IMPATTO DEL COVID-19 SUL MERCATO DELLO SCREENING DEI FARMACI Il COVID-19 ha comportato notevoli interruzioni per le imprese e le attività commerciali a livello globale. Sono state imposte restrizioni e blocchi anche nei viaggi, nelle operazioni commerciali, nelle riunioni pubbliche e negli ordini di residenza sul posto, che hanno avuto un ulteriore impatto sulla crescita del mercato. Tuttavia, si prevede che avrà un’influenza negativa a breve termine sul mercato dello screening farmacologico a causa della disponibilità limitata o inesistente di reparti medici o centri di trattamento, di fornitori di servizi che riducono il danno e del timore di trasmissione di infezioni. Inoltre, varie autorità in tutto il mondo hanno fornito linee guida per rinviare o ritardare i sistemi medici e chirurgici non essenziali per ridurre la pressione sul sistema sanitario e diminuire la trasmissione delle malattie. ATTORI DI MERCATO Il rapporto copre gli sviluppi chiave nel mercato dello screening farmacologico come strategie di crescita organica e inorganica. Diverse aziende si stanno concentrando su strategie di crescita organica come lanci di prodotti, approvazioni di prodotti e altri come brevetti ed eventi. Le attività di strategie di crescita inorganica testimoniate nel mercato sono state acquisizioni, partnership e collaborazioni. Queste attività hanno aperto la strada all'espansione del business e della base clienti degli operatori del mercato. Si prevede che i pagatori del mercato dello screening farmacologico avranno opportunità di crescita redditizie in futuro con la crescente domanda di screening farmacologico nel mercato globale. Il rapporto include anche i profili delle principali aziende insieme alle loro analisi SWOT e strategie di mercato nel mercato dello screening farmacologico. Inoltre, il rapporto si concentra sui principali attori del settore con informazioni quali profili aziendali, componenti e servizi offerti, informazioni finanziarie degli ultimi 3 anni e lo sviluppo chiave degli ultimi cinque anni.
    •  Abbott •  Omega Laboratories, Inc. •  Servizi di monitoraggio Roche. •  Siemens Healthcare GmbH •  Thermo Fisher Scientific Inc. •  Quest Diagnostics Incorporated •  Premier Biotech, Inc. •  OraSure Technologies, Inc. •  Psychemedics Corporation •  Laboratory Corporation of America Holdings
Il team di ricerca e analisi dedicato del partner Insight è composto da professionisti esperti con competenze statistiche avanzate e offre varie opzioni di personalizzazione nello studio esistente.
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the Drug Screening Market

Drug Screening Marketis expected to grow at a CAGR of 16.5% between 2023-2031

What are the driving factors impacting the Drug Screening Market

The driving factors impacting the Drug Screening Market are: Efficient Drugs, Drug Discovery and Technological Advancements

What are the future trends of the Drug Screening Market

The future trends of the Drug Screening Market are: Automation and High-Throughput Screening, Artificial Intelligence and Machine Learning

Which are the leading players operating in the Drug Screening Market

The leading players in the Drug Screening Market are: Alpine Electronics, Inc., Clarion Company, Ltd, Continental AG, Delphi Automotive plc, Denso Corporation, Garmin, Ltd., Harman International Industries, Inc., Panasonic Corporation, Robert Bosch GmbH, Visteon Corporation

What are the deliverable formats of the Drug Screening Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Abbott
2. Omega Laboratories, Inc.
3. Roche Monitoring Services.
4. Siemens Healthcare GmbH
5. Thermo Fisher Scientific Inc.
6. Quest Diagnostics Incorporated
7. Premier Biotech, Inc.
8. OraSure Technologies, Inc.
9. Psychemedics Corporation
10. Laboratory Corporation of America Holdings
11. Alere, Inc
12. Drägerwerk AG & Co. KGAA
13. Biorad Laboratories, Inc.
14. Danaher Corporation
15. Express Diagnostics International Inc.


Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.